Sign In
STTK.US
id: 770

Shattuck Labs Inc. (STTK) $1.4M Shareholder Settlement

E.D. New York
Court
1:22-cv-00560-CBA-RML
Case number
09 Oct 2020
Class period Start
08 Nov 2021
Class period End
30 Sept 2023
Claim deadline
Shattuck Labs Inc. (STTK) pays $1.4 million to shareholders to settle a class action over an IPO supporting materials that alleges that:
  1. Collaboration Agreement with Takeda was not solid;
  2. Takeda and Shattuck would “mutually agree” to terminate the Collaboration Agreement in essentially one year;
  3. as a result, Shattuck would cease to receive any future milestone, royalty, or other payments from Takeda; and
  4. as a result, the statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
All who purchased the common stock of Shattuck Labs, Inc. between October 9, 2020, and November 8, 2021, both dates inclusive, including in Shattuck’s October 9, 2020 IPO, and held such shares past November 8, 2021, may be eligible to receive a payment.
Case Status
Disbursement
Alleged Offence
Misleading Statements
Financial Misrepresentation
Failure to Disclose
Omissions
Suspected Party
Directors
Management
Investment Bank
Service Provider
Security Type
Stocks
Trade Direction
Long
Payout per Share
0.033
Filing date
31 January 2022
Attorneys
The Rosen Law Firm
Defendants
Shattuck, Taylor Schreiber, Andrew Neill, Josiah Hornblower, Helen M. Boudreau, Neil Gibson, George Golumbeski, Michael Lee, Tyler Brous
Judge
Hon. Carol B. Amon
Administrator
Strategic Claims Services
Court hearing date
30 October 2023
Exclusion deadline
09 October 2023
Objection deadline
09 October 2023
Hearing deadline
09 October 2023
Trades matching type
FIFO
+$1,400,000
Cash Settlement Amount

Shattuck Labs Inc

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is S...

    Ticker
    STTK.US
    ISIN
    US82024L1035
    CIK
    1680367
    Sector
    Healthcare
    Industry
    Biotechnology
    Country
    USA
    Address
    500 West 5th Street, Austin, TX, United States, 78701